[1]
“ Synthesis and biological evaluation of 125I-erythropoietin as a potential radiopharmaceutical agent for tumours ”, Braz. J. Pharm. Sci., vol. 47, no. 1, pp. 83–88, Mar. 2011, doi: 10.1590/S1984-82502011000100010.